Obstructive Sleep Apnea and Polycythemia at High Altitude

Physiological Effects of High Altitude

High altitude exposure (>2,500m) triggers physiological acclimatization processes including increased respiratory rate, tidal volume, and sympathetic nervous system activation, according to the European Society of Cardiology 1, 2
These adaptations lead to increased heart rate, stroke volume, and eventually increased red cell mass and blood oxygen carrying capacity, as stated by the European Heart Journal 2
Altitude-induced hypoxia is a potent stimulus for erythropoietin production, leading to increased hemoglobin mass by approximately 1.0-1.1% for every 100 hours of hypoxic exposure, as reported by the American College of Sports Medicine 3, 4

Patients with OSA living at high altitude should be monitored for polycythemia due to the additive effects of both conditions, as recommended by the European Heart Journal 2

Hemoglobin increases predictably with altitude, with an expected increase of approximately 0.2 g/dL at 1,000m, 0.8 g/dL at 2,000m, 1.9 g/dL at 3,000m, and 3.5 g/dL at 4,000m above sea level 5

The maximum rate of ascent above 2,500m should not exceed 300-600 m/day, with rest days every 600-1,200m gained, as recommended by the American Heart Association, to reduce altitude-related complications 6